Seal-G
Commercial- Indications
- Gastrointestinal surgery
Company intelligence / Profile preview
Sealantis
Haifa, Israelsealantis.com ↗
- Ownership
- Private
- Employees
- ~13
- Development stage
- Commercial
01
Overview
Sealantis developed a proprietary platform based on alga-mimetic adhesives inspired by the way algae adhere to rocks underwater. Its lead product, "Seal-V", received CE Mark approval and was commercialized in Europe to reduce blood loss during vascular surgeries by sealing suture lines. The company’s adhesives are protein-free, reducing infection/allergy risk compared to animal-derived products. Clinical studies demonstrated safety and efficacy for controlling bleeding from large peripheral blood vessels. The company was acquired by Advanced Medical Solutions Group in early 2019 for $25 million plus royalties; it now serves as an innovation center within AMS.
- Therapeutic areas
- HematologyOtherGastroenterologyCardiovascularNeurology
- Modalities
- Device (specifically, alga-mimetic tissue adhesive/sealant)Hydrogel-based drug delivery therapy (the technology involves hydrogels based on alginate polymers)
- Industry
- Surgical Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Sealantis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sealantis.